交易中 04-01 09:52:29 美东时间
+0.995
+1.74%
今日重点评级关注:HC Wainwright & Co.:维持Helus Pharma"买入"评级,目标价从55美元升至95美元;HC Wainwright & Co.:维持Compass Pathways"买入"评级,目标价从40美元升至70美元
03-03 20:22
Goldman Sachs Research analysts updated their U.S. conviction list Monday as the new month kicked off, adding ConocoPhillips (COP) and Loar Holdings (LOAR) while removing Huntington Ingalls Industries...
03-03 04:43
华盛资讯3月3日讯,Loar Holdings Inc.公布2025财年年度业绩,公司年度营收4.96亿美元,同比增长23.2%,归母净利润0.72亿美元,同比增长224.5%。
03-03 03:47
Citigroup analyst John Godyn maintains Loar Holdings (NYSE:LOAR) with a Buy and raises the price target from $81 to $83.
03-03 02:57
华盛资讯2月26日讯,Loar Holdings Inc.公布2025财年Q4业绩,公司Q4营收1.32亿美元,同比增长19.3%,归母净利润0.13亿美元,同比增长239.5%。
02-26 21:51
Loar Holdings (NYSE:LOAR) released its Q4 earnings on Thursday, February 26, 20...
02-26 21:34
Loar Holdings (NYSE:LOAR) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.19 by 34.72 percent. This is a 136.36 percent increase over earnings of $0.11 per share from the
02-26 21:33
今日重点评级关注:杰富瑞:上调BioAge Labs评级至"买入",目标价从9美元升至62美元;RBC Capital:维持COMPASS Pathways Plc Sponsored ADR"跑赢大市"评级,目标价从21美元升至22美元
02-19 16:21
RBC Capital analyst Ken Herbert maintains Loar Holdings (NYSE:LOAR) with a Outperform and lowers the price target from $92 to $90.
02-19 00:09
Loar Holdings Inc. to Announce Q4 and Full Year 2025 Earnings Loar Holdings Inc. will release its fourth quarter and full year 2025 earnings before the market opens on February 26, 2026. Results will be available through the Investor section of the Loar Holdings website. A conference call to discuss
02-12 21:30